Getting closer to regulatory harmony in a shrinking pharma world
This article was originally published in SRA
Executive Summary
Gill King and Joel Finkle explore some of the key developments relating among other things to document submission that have taken place over the past year in major pharmaceutical markets and what those developments mean for the industry.